Jeff is passionate about building companies using technology and science for impact. He has fifteen years of business, executive management, and entrepreneurial experience principally in the biotech and technology industries.

He is CEO and Co-Founder of Engine Bio, a venture-backed biotech company based in Singapore and SF Bay Area. Engine deploys its proprietary machine learning and next-generation CRISPR screening platform to interrogate gene networks and identify right targets and biomarkers for drug discovery.  Working in oncology and neurodegeneration, Engine has a rich pipeline of targets and preclinical development programs.  In addition to Engine, Jeff has played founding and leadership roles in several biotechnology and technology companies. This includes Enleofen Bio (developing therapeutics targeting IL-11 for fibrosis; preclinical pipeline acquired by Boehringer Ingelheim for >$1 billion), PairX Bio (venture-backed cancer immunotherapy company), and AAE (travel technology company built to substantial revenue and profitability within three years of inception; acquired by Expedia Inc in transactions valuing AAE at ~$300 million), among others.

Jeff began his career as a management consultant at Bain & Company. Subsequently he joined AirAsia as Head of Strategy and Group Head of Commercial Strategy, leading teams covering strategy, commercial strategy, data analytics, and digital marketing. He played a principal role in establishing several new joint ventures and businesses for the group.

Jeff has been named a Young Global Leader by the World Economic Forum. He received his BA summa cum laude from University of Pennsylvania.